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Abstract
Mapping of expression quantitative trait loci (eQTLs) is an important technique for studying how genetic variation affects
gene regulation in natural populations. In a previous study using Illumina expression data from human lymphoblastoid cell
lines, we reported that cis-eQTLs are especially enriched around transcription start sites (TSSs) and immediately upstream of
transcription end sites (TESs). In this paper, we revisit the distribution of eQTLs using additional data from Affymetrix exon
arrays and from RNA sequencing. We confirm that most eQTLs lie close to the target genes; that transcribed regions are
generally enriched for eQTLs; that eQTLs are more abundant in exons than introns; and that the peak density of eQTLs
occurs at the TSS. However, we find that the intriguing TES peak is greatly reduced or absent in the Affymetrix and RNA-seq
data. Instead our data suggest that the TES peak observed in the Illumina data is mainly due to exon-specific QTLs that
affect 39 untranslated regions, where most of the Illumina probes are positioned. Nonetheless, we do observe an overall
enrichment of eQTLs in exons versus introns in all three data sets, consistent with an important role for exonic sequences in
gene regulation.
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Introduction
Polymorphisms that impact gene regulation play an important
role in disease genetics and adaptive evolution [1,2]. One
important tool for identifying such variants is by genome-wide
mapping of expression quantitative trait loci (eQTLs) [3–5]. A
number of recent studies have aimed to characterize the properties
of genetic variants that produce eQTLs, including the types and
locations of variants, and the functional context of the variants in
question [6–12].
In previous work, we developed a Bayesian hierarchical method
for studying the distribution of eQTLs with respect to their target
genes, and for identifying biological anotations that can predict the
locations of causal sites [9,11]. Applying that method to Illumina
expression array data collected in the HapMap lymphoblastoid
cell lines, we observed a striking enrichment of eQTLs
immediately upstream of the TES [9], in addition to a more
expected enrichment around the TSS of the target genes [7,8]. In
that paper we proposed two main hypotheses to explain the
presence of the eQTL peak in the 39 UTR: (1) these may be
variants that affect stability or degradation of the entire transcript
(e.g., miRNA binding sites), or (2) these may be variants that affect
inclusion levels of the last exon (e.g., splicing QTLs; note that most
of the Illumina probes lie in the last exon). In the original paper we
argued that the first mechanism was likely to be most important.
However, in a more recent study using RNA sequencing to
measure isoform expression levels for a subset of the HapMap
LCLs we did not find a peak of eQTLs at the TES [13].
Here we revisit the TES peak to understand better the
mechanism that generates this intriguing signal. Using expression
data for the same samples from independent experiments and
different technologies, our new analysis suggests that in fact exon-
specific effects are responsible for most, if not all of the 39 UTR
peak that we saw previously. However, we find that our previous
result showing an eQTL enrichment in exons overall, compared to
introns is supported by all three data sets.
Results
Datasets and cis-eQTL mapping
For this analysis we used data from the 210 unrelated HapMap
samples in the original HapMap Phase I/II cell lines [14]. These
include 60 CEPH (CEU), 60 Yoruba (YRI), 45 Chinese (CHB)
and 45 Japanese (JPT) samples. The SNP genotypes were based on
HapMap genotypes for all HapMap SNPs, combined with whole-
genome sequence data from the 1000 Genomes Project [15]. For
individuals not sequenced by the 1000 Genomes Project, missing
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e30629SNP genotypes were imputed using BIMBAM [16,17]. See the
Methods for further details.
We analyzed expression measurements obtained using three
distinct technologies:
N Illumina gene array data from a total of 210 CEU, CHB, JPT
and YRI samples [6] and hereafter referred to as the Illumina
data set. This is the expression dataset we used for our previous
study [9];
N Affymetrix exon array data from 117 CEU and YRI samples
[18] and hereafter referred to as the Affymetrix data set;
N RNA sequence data from 102 CEU and YRI samples [13,19],
hereafter referred to as the RNA-seq data set.
Note that the 117 individuals in the Affymetrix data set, and 102
individuals in the RNA-seq data set are both subsets of the 210
individuals in the Illumina data set (and in both cases include the
majority of the CEU and YRI samples). The original RNA-seq
data sets included a few individuals that were not in either the
Illumina data or Phase I/II HapMap; in order to simplify the
genotype imputation pipeline these individuals were excluded
from the analysis.
To avoid the impact of spurious associations caused by SNPs
falling within the probes of the two array data sets (Illumina and
Affymetrix), we systematically removed all probes containing at
least one SNP. We also removed all probes impacted by short
insertions/deletions or copy number variations (CNV) based on
the genomic coordinates of these structural variants as provided by
[20] and the 1000 Genomes Consortium [15]. Finally, for all
expression data we removed probes (Illumina and Affymetrix) or
exons (RNA-seq) that appear to be ‘‘non-expressed’’ (see Materials
and Methods). For each dataset, expression levels were quantile
normalized to a standard normal distribution within populations
prior to performing the mapping of cis-eQTLs, in order to avoid
false positives due to population structure [9]. More extensive
details on the data processing are provided in the Materials and
Methods section. Table S1 provides a summary of the content of
each expression dataset.
For eQTL mapping, we used standard linear regression to test
every SNP within the transcript or 100 kb from either end of the
transcribed region for association with gene expression. Table S1
reports the number of eQTLs we found for each expression
dataset for an empirically estimated False Discovery Rate (FDR) of
5%. For each gene with at least one significant SNP, we treated
the most significant SNP as an estimate of the major eQTN
(Quantitative Trait Nucleotide) for that gene. When more than
one SNP had exactly the same lowest p-value (e.g., several SNPs in
perfect LD) we equally shared the probability of being the major
eQTN among all these SNPs.
The TES peak is strongest in the Illumina data and absent
in the RNA-seq data
The left panels of Figure 1 display the distribution of locations of
the best SNP with respect to the target gene (similar to Figure 2 of
[9]): the vertical red arrow on each panel highlights the location of
the Illumina TES peak. As is evident, the peak upstream of the
TES is strongest in the Illumina data, weaker in the Affymetrix
data, and essentially absent from the RNA-seq data.
To assess the evidence for a TES peak more quantitatively, we
computed the AIC (Akaike Information Criterion) for a model
with, and without a special TES effect (Figure 1; compare the
‘‘TSS, intron, exon’’ model to the ‘‘TSS, intron, exon, last exon’’
model). As illustrated in the figure, the model with a special effect
for the last exon (i.e, the exon ending at the TES) is strongly
preferred for the Illumina data (by 188 units of likelihood), it is
weakly preferred for the Affymetrix data (by 7 units), and weakly
disfavored for the RNA-seq data (by 2 units).
One major difference between the Illumina data and the other
two data sets is that a large fraction of the Illumina probes are
positioned in the last exon (85% for Illumina compared to 21% for
Affymetrix). To assess whether the Illumina probe placement
might have helped to create the peak of signals at the TES, we
filtered the Affymetrix data to include only those Affymetrix
probes that are in the same exon as an Illumina probe (and hence
the filtered data set includes mainly probes in the last exons of
genes). When we did this, we observed that indeed the filtered
Affymetrix data set showed a much stronger peak of eQTLs in the
last exon (Figure 2). This latter observation strongly suggests that
the probe distribution on the Illumina array has helped to create
an apparent peak of eQTLs in the last exon that is not supported
by the other data sets.
In principle, one plausible explanation might be that ungeno-
typed SNPs in Illumina probes could generate spurious eQTL
signals, and that these would often be detected by nearby SNPs;
such an effect might in principle generate a spurious 39 peak of
eQTLs. However, this does not appear to be the case. The original
analysis of Veyrieras et al included a correction factor for
unmeasured SNPs-in-probes that suggested that the effect of such
SNPs was relatively modest [9]. That conclusion is confirmed by
the analysis presented here, for which we removed all probes
containing 1000 Genomes SNPs (which should include nearly all
common SNPs in probes); the distribution of eQTNs in the
Illumina data is very similar to the corrected distribution reported
previously [9].
eQTNs within last exons frequently have exon-specific
effects on expression
Recent work has shown that there are many SNPs that impact
the expression levels of individual exons, while not necessarily
affecting the overall expression levels of genes [13,19,21,22]. Such
QTLs are often referred to as ‘‘splicing-QTLs’’ (sQTLs) although
in some cases they arise through other mechanisms than splicing
changes per se (for example, changing the transcription end site
position [22]). Fraser and Xie, who also analyzed the Affymetrix
data, reported that the last exon is particularly prone to exon-level
QTLs [21]. Given these observations, we conjectured that the
TES peak of eQTLs in the Illumina data may be caused by SNPs
that lie in or near the last exon, and that affect expression levels of
the last exon only.
To evaluate this hypothesis, we computed exon-specific
expression levels in each individual using both the Affymetrix
and the RNA-seq data sets, controlling for the overall expression
level of the gene in that individual to remove the impact of gene-
level eQTLs (see Materials and Methods). We then tested whether
eQTNs identified using the Illumina data would replicate at either
the exon level (as sQTLs) or at the gene level (as eQTLs) in the
Affymetrix and RNA-seq data sets. For each gene with a
significant eQTL in the Illumina data set (FDR=5%), we
designated the most significant SNP as a putative Illumina eQTN.
(In many cases the putative eQTNs will not be the true causal sites,
but they should at least be in strong LD with the causal sites). For
this set of eQTNs we classified each SNP according to its position
within the corresponding gene: i.e., the SNP was either in the first,
internal or last exon, or it was intronic, or intergenic. We tested
each eQTN for association both at the gene level (for the gene
identified by the Illumina analysis) and at the exon level (for each
exon from that gene that was within 10 kb of the eQTN). Each
exon-level test was treated as an independent test.
Distribution of eQTLs and Gene Expression Arrays
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e30629Figure 1. Expression QTN distributions estimated using three different technologies for measuring gene expression. The left-hand
column plots the distribution of locations of most significant SNPs for each technology; the red arrows indicate the location of the TES peak observed
in the Illumina data. SNPs outside genes are assigned to bins based on their physical distance from the TSS (for upstream SNPs), or TES (downstream
SNPs). SNPs inside genes are assigned to bins based on their fractional location within the gene. The plotted gene size is the average gene length in
the data. To provide a formal comparison among different models, the right-hand column displays the difference in Akaike Information Criterion (AIC)
values between different parameterizations of our Bayesian hierarchical model (see Methods and Table 1). Small values of D‘‘(AIC’’) indicate better
model fit, and the best model for each data set is indicated with a horizontal arrow. The labels for the four models indicate the different parameters
included in each model: ‘‘TSS’’ refers to our basic distance model measured as distance from TSS; ‘‘intragenic’’ means that we use a single additional
parameter for all SNPs within the transcript; ‘‘exon, intron’’ indicates that we use separate parameters for exonic and intronic SNPs respectively, and
‘‘last exon’’ indicates that we add an additional parameter for SNPs in the final exon.
doi:10.1371/journal.pone.0030629.g001
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eQTNs are more likely than other Illumina eQTNs to be sQTNs
in the Affymetrix data. Conversely, last exon Illumina eQTNs are
less likely than other categories of SNPs to replicate at the gene
level in the Affymetrix data (Figure 3A, right panel). Although less
striking, Figure 3B shows that the RNA-seq data exhibit a very
similar pattern. (Note that the RNA-seq analysis of splicing-QTLs
is thought to be underpowered in this data set, except for the most
highly expressed genes (see Supplementary Figure 15 of [13]),
which may explain why the enrichment of last-exon QTLs is lower
for the RNA-seq data than for the Affymetrix data.)
As an illustration, Figure 4 provides an example of a highly
significant Illumina eQTL (p=3|10{27), for which the most
significant SNP lies within the 39 UTR. However, analysis of the
Affymetrix data indicates that the effect of this SNP is primarily
through an exon-specific effect on the last exon (and indeed there
maybeaseparate oppositeeffect on exon 2). In summary, we interpret
Figure 3 as evidence that the 39 peak of eQTLs that was detected in
the Illumina data is largely due to a large number of exon-level
QTLs that were detected by 39 UTR probes in the Illumina arrays.
eQTN enrichment within exons is reproducible between
platforms
In our previous work, we also reported a 2-fold enrichment of
eQTNs within internal exons compared to introns [9]. Given our
newer observations regarding the TES peak, we thus asked
whether this exon enrichment is robust across platforms. To
evaluate this, we performed a gene-level analysis of all three data
sets using our empirical Bayesian framework (see Materials and
Methods). We considered four different nested models for the
distributions of eQTNs:
0. TSS: the model accounts only for distance from the TSS;
1. TSS, intragenic: same as previously plus an annotation for SNP
being within the transcribed region of the target gene;
2. TSS, intron, exon: as previously but the intragenic annotation
is split into exclusive intron and exon categories;
3. TSS, intron, exon, last exon: as previously but the exon
category is split into exclusive exon (except the last) and last
exon categories.
For each of the three data sets, we ran each model separately
and then selected the best model based on the Akaike Information
Criterion (AIC).
Figure 1D plots for each data set the difference between each
model and the best one (i.e., the model with the smallest AIC
value). Table 1 also reports the odds ratio estimates of the
parameters under each model and for each dataset. As noted
above, Model 3 (which includes the special last exon effect) is
strongly favored by the Illumina data, weakly favored by the
Affymetrix data, and weakly disfavored by the RNA-seq data.
However, in contrast, all three data sets agree that Model 1 is
significantly better than Model 0 (implying a general enrichment
of eQTNs within transcribed regions), and that Model 2 is
significantly better than Model 1 (implying an enrichment of
eQTNs within exons compared to introns).
Discussion
In this analysis we have shown that the sharp peak of eQTNs
previously observed at the TES in Illumina eQTL data [9]
appears to be largely driven by SNPs with exon-specific effects.
Our results highlight the point that for arrays that probe only a
single exon of each gene, it is not possible to distinguish between
gene-level and exon-level QTLs. It appears that the majority of
eQTLs detected using the Illumina arrays are in fact at the
gene-level; however the number of exon-level QTLs is high
enough to substantially shift the distribution of QTNs and to
complicate the interpretation of eQTLs. In contrast, the gene-level
RNA-seq data (and to a lesser extent the Affymetrix data) should
be much less sensitive to exon-level effects for most genes, except
perhaps when one exon represents a large fraction of the total gene
length.
Unlike the TES signal, however, we find that the previously
reported enrichment of eQTNs within exons compared to introns
[9] is verified in both the Affymetrix and RNA-seq data sets. This
suggests that there is an enrichment of regulatory elements within
exons. A natural hypothesis is that a fraction of these exonic
elements may affect properties of the processed mRNA, rather
than affecting transcription rates. These exonic elements may be
involved in processes such as promoting mRNA stability or
degradation, although further work will be required to test this.
Figure 2. Expression QTN distribution estimated using only those Affymetrix probes that are located within the same exon as an
Illumina probe creates an apparent 39 signal peak. Overall, the Affymetrix probes are spread roughly evenly across exons while the Illumina
probes are 39 biased. By analyzing only those Affymetrix probes that are in the same exons as Illumina probes, we create an apparent 39 signal peak.
For the sake of comparison, the grey line represents the original distribution as plotted in Figure 1.
doi:10.1371/journal.pone.0030629.g002
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eQTNs within transcribed regions, controlling for distance from
the TSS. That is, a SNP at a distance x kb downstream from the
TSS of gene y is more likely to be an eQTN if it lies inside the
transcribed region of y than if it does not. This suggests that long
genes may, on average, establish larger domains of cis-regulatory
control than do short genes.
In summary, we have shown that the TES peak of eQTLs that was
observed previously was most likely driven by QTLs affecting the last
exon only. In addition, we have confirmed the enrichment of eQTNs
within exons compared to introns; and in transcribed regions
compared to downstream intergenic regions, controlling for distance.
Methods
Genotype data
For this project we used data from 210 unrelated individuals
studied in Phases I and II of the HapMap Project (i.e., all the
Chinese and Japanese individuals plus the parents from the
Yoruba and CEU trios). The genotype estimates were based on a
combination of the 1000 Genomes and HapMap data. These
genotypes should include most common variants in the non-
repetitive fraction of the genome. For all HapMap SNPs we used
the HapMap genotype calls from release 24 of HapMap Phase II
[14]. For 141 of these individuals (44 Yoruba (YRI), 30 Japanese
Figure 3. Illumina last exon expression-QTLs are more likely to be splicing-QTLs. We determined the most significant SNP for each Illumina
eQTL, and then tested every such SNP for association at the gene- and exon-levels using the Affymetrix and RNA-seq data. Here we show QQ-plots for
these Illumina eQTNs in the exon-level analysis (left) and the gene-level analysis (right), using the Affymetrix exon array data (top) and RNA-seq data
(bottom). The color codes correspond to 5 exclusive categories of the Illumina eQTNs with respect to the target gene: intragenic, exonic ‘‘(first,
internal and last) or intronic (intron). Note that last-exon Illumina eQTNs tend to replicate well at the exon level, but poorly at the gene level,
suggesting that these are frequently exon-QTLs but infrequently gene-QTLs.
doi:10.1371/journal.pone.0030629.g003
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additional data from the final SNP call set of the 1000 Genomes
Consortium pilot data (released March 2010) [15]. Note that for
sites that are in both Phase I/II of HapMap and in 1000
Genomes, we used the HapMap data, since these are available
for all 210 individuals and are likely to have slightly lower error
rates. For the remaining 69 individuals we imputed genotypes
at 1000 Genomes SNPs using BIMBAM [16,17]. We excluded
SNPs with MAF v1%. Our final SNP data set consisted of a total
of 3.3 M HapMap SNPs and a further 11.3 M 1000 Genomes
SNPs.
Expression data
All the expression datasets were preprocessed using the same
gene models, based on the hg18 Ensembl gene annotation track
downloaded from the UCSC web site on 12/31/2009.
Illumina gene array. We used data from the 210 unrelated
individuals in Stranger et al. (2007) [6] (i.e., excluding children
Figure 4. SNP rs8984, located within the last exon of gene CHURC1, primarily affects expression of the last exon, but is interpreted
by the Illumina analysis (which has only one probe in this gene) as a gene level QTL. For each panel, we display quantile-normalized
expression levels. Data for each genotype at SNP rs8984 are repre- sented with the same color code (orange, grey and green) for all the panels. The
top panel plots the mean exon expression levels along the gene as measured by the Affymetrix probes and provides on top of each exon the p-value
for the association between the exon expression levels and the SNP genotypes. The blue vertical bar indicates the position of the single Illumina
probe. The middle panel is a schematic representation of the gene: exons are plotted as black/green rectangles where the green color indicates
coding regions. The position of SNP rs8984 is indicated by a red arrow. The bottom panel provides the box plots corresponding to each analysis: from
left to right, specific Affymetrix last exon expression levels (p-value=3610
211), Affymetrix gene expression levels (p-value=0.04) and Illumina gene
expression levels (p-value=3610
227).
doi:10.1371/journal.pone.0030629.g004
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from the array to build 36 (hg18) of the human genome using
MAQ [23], selecting only those probes which matched a single
unique location with zero mismatches. Of the 47,296 probes on
the array, 41,729 fulfilled these criteria. We next selected only
those probes that overlapped an annotated exon or exon-exon
boundary. We found that 18,478 probes mapped to known
exons.
Then we removed ‘‘non-expressed’’ probes by visual inspection
of a median versus median absolute deviation (MAD) scatter plot
augmented with the fraction of expressed genes at a given MAD
value as derived from the RNA-seq datasets. From this
visualization it is clear that there are two populations of probes,
one ‘‘expressed’’ population with moderate to high MAD values
and a ‘‘non-expressed’’ population of probes with low MAD
values. This analysis indicated that probes with low MAD are
generally non-expressed. We thus removed 8,214 ‘‘non-expressed’’
probes from the original set which yields a core set of 10,264
probes.
Since expression measurements are susceptible to large
technical variability and since we are looking only at cis-eQTLs,
we performed a principal component-based adjustment of the
expression dataset similar to what it has been previously described
by our group [13] and in other studies [24–27]. To do so we first
adjusted each expression measurement yi,j by subtracting the
population mean value for gene j in the population of individual i,
in order to bring all populations to the same mean value. We next
performed principal components analysis on the expression
matrix. By doing 100 permutations of the population-adjusted
probe expression values we derived an empirical distribution of the
PC eigenvalues under the null hypothesis assuming independence
of all probes. We then selected the optimal number of PCs by
choosing the last PC for which the observed eigenvalue exceeds
the upper 97.5% percentile of the empirical null distribution as
derived by our bootstrap procedure. With this procedure we
retained 26 PCs that we then regressed out probe-by-probe using
an elastic-net [28] linear model which also includes the population
and the sex covariates for each sample. Briefly, an elastic-net
regression was performed for each probe by using an in-house C
implementation of the standard LARS-EN procedure [28].
Regarding the tuning parameter l we used a discrete grid of
6 points (0:001,0:01,0:1,1,10,100) corresponding to almost Lasso
behavior (l~0:001) to almost ridge behaviour (l~100). For each
probe, the optimal value of l was obtained by applying a leave-one
out cross-validation procedure: for each individual left out we thus
computed the squared difference between the actual probe
expression value of this individual and the one predicted by the
elastic-net linear model learned only with the other individuals.
The optimal value of l is then the one that minimizes the residual
sum of squares across individuals. We then derived for each probe
the corresponding corrected expression levels by computing the
residuals from the optimal elastic-net linear regression model.
These corrected probe expression levels were then used for all
subsequent analyses. Finally, we removed all probes that
overlapped with any known variant including SNPs, copy number
variants and short insertions/deletions [15,20].
Affymetrix exon array. We downloaded the raw Affymetrix
Human Exon 1.0 ST array CEL files published by Huang et al.
(2007) [18] from GEO (GSE7792). As for the Illumina array, we
first remapped the probes to build 36 (hg18) of the human genome
using MAQ [23], selecting only those probes which matched a
single unique location with zero mismatches. The probe sequences
were obtained from the Affymetrix website (http://www.
affymetrix.com/Auth/analysis/downloads/na25/wtexon/HuEx-1
_0-st-v2.probe.tab.zip). Of the 5,431,924 probes on the array,
4,839,062 fulfilled these criteria. We next selected only those probes
that overlapped an annotated exon while removing probes
interrogating exons shared by at least two distinct genes (66,347
probes). This yields a core set of 1,355,061 single gene exonic
probes.
We performed GC-bin background correction of each array
followed by a quantile normalization on natural scale within each
population (CEU and YRI) using an in-house implementation. We
then removed ‘‘non-expressed’’ probes defined as probes with a
median normalized intensity level below 24 within both popula-
tions (this is based on visual inspection of both the distribution of
the normalized median probe expression levels within each
population and the probability that the probe intensity is not
drawn from the distribution of background intensities empirically
defined by the corresponding matched GC content negative-
controls probes). For the final set of 1,060,605 pre-processed
exonic probe expression levels and as for the Illumina dataset, we
performed a principal component-based adjustment by combining
the expression levels from both populations. Using the same
approach as previously described we thus regressed out the effect
of 35 PCs including population and sex covariates within the
elastic-net model. Finally, as for the Illumina dataset, we used a
conservative approach and removed all the probes which overlap
with a 1000 Genomes SNP inside yielding to a final core set of
444,306 exonic probes.
Table 1. eQTN enrichment within exons is strongly supported by all three datasets while there is relatively weak evidence that the
last exon is special.
Model Annotation Odds Ratio Estimates [95%CI]
Illumina Affymetrix RNA-seq
1 intragenic/intergenic 7.51 [6.70, 8.43] 4.25 [3.29, 5.53] 9.12 [6.36, 13.41]
2 exon/intron 12.13 [10.78, 13.60] 11.13 [8.54, 14.33] 6.68 [4.37, 9.89]
3 exon (except last)/intron 5.95 [5.05, 6.96] 8.67 [6.42, 11.49] 7.29 [4.69, 10.94]
3 last exon/intron 28.66 [24.71, 33.13] 21.46 [13.69, 31.94] 4.03 [0.86, 10.50]
The table displays the odds ratio estimates together with their corresponding 95% confidence intervals, as estimated by the empirical Bayesian model (see Methods) for
each expression dataset (Illumina, Affymetrix, RNA-seq). Model 1 (TSS, intragenic) estimates the odds ratio that a SNP inside the transcribed region is an eQTN compared
to a SNP outside the transcribed region (controlling for distance from TSS). For Model 2 (TSS, intron, exon) and Model 3 (TSS, intron, exon, last exon) we used the intron
annotation as the reference: the reported exon and last exon odds ratio can then be interpreted as the relative odds that a SNP within these regions is an eQTN with
respect to an intron SNP at the same distance from the TSS.
doi:10.1371/journal.pone.0030629.t001
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summarization approach based on the median polish procedure
[29,30]. Briefly we considered all the probes that span the entire
transcribed region and build a two-way layout matrix where the
probes are in columns and the samples in rows. We then fit the
additive model yi~mizpjzei, where yi is the gene expression
level for sample i, pj is the effect of probe j and ei is the residual, by
iteratively removing the median of rows and columbs until
convergence. As mentioned in the main text we also considered an
alternative by applying the median polish procedure first at the
exon level followed by a second median polish procedure on the
sample x exon expression matrix to get the gene expression levels.
Finally, to perform our splicing-QTN mapping we computed
splicing exon expression levels as described in [31]: specific exon
expression levels are thus derived from the residuals of the gene
level median polish procedure. Note that for sQTN mapping we
used only exons from genes having at least two exons with
expression level measurements (85,524 exons from 6,884 distinct
genes).
RNA-seq analysis. We obtained published RNA-seq data
from 60 CEU individuals and 75 YRI individuals [13,19]. Both
data sets were pre-processed roughly as described in the
Supplementary Information of Pickrell et al. [13]. We performed
the correction for GC content as described using all 135
individuals together.
From the original 241,639 exons we removed 118,548 exons for
which the median counts within both populations were 0. Using
this core set of 123,091 exon level expression measurements we
performed a PCA-based adjustment but this time separately within
each population (since sequencing was performed in two distinct
environments each one may have its own hidden factor structure).
Thus, including sex as a covariate, we regressed out 12 specific
PCs for the YRI dataset and 16 other specific PCs for the CEU
dataset.
For subsequent analyses, we used only the 43 CEU and 59 YRI
samples that were included within our genotype dataset. As for the
expression arrays, gene expression levels were computed by
applying a median polish procedure onto the sample x exon
expression level matrix, thus removing exon specific effects.
Similarly specific exon expression levels have thus been derived
from the residuals of the gene level median polish procedure [31].
As for the Affymetrix dataset, sQTN mapping is based only on
exons from genes having at least two exons with expression level
measurements (91,960 exons from 8,658 distinct genes).
Analyses
For the technical details of the statistical analyses we invite the
reader to refer to our previous article [9]. The main differences
here are:
N for eQTN mapping we restricted the cis-candidate region to
100 kb around both gene ends (instead of 500 kb),
N for sQTN mapping we used a 10 kb window around both
exon ends, since it has been previously show that sQTNs are
mainly concentrated nearby the spliced-exon [13].
The exon-level FDR for the sQTN analysis has been obtained
in the same way as the gene-level FDR described in [9]. Finally,
the extension of our empirical Bayesian model is detailed in [11].
Supporting Information
Table S1 Summary of the three expression datasets
used in this study. For Illumina and Affymetrix datasets the
number of probes corresponds to the final number of probes used
after filtering. Both the number of eQTNs and sQTNs are
reported for an empirically estimated FDR of 5% (see Material
and Methods). For eQTNs, the corresponding p-value cutoffs are:
i) Illumina (p-value~5|10{5), ii) Affymetrix (p-value
~8|10{6), iii) RNA-seq (p-value ~3|10{6). For sQTNs the
p-value cutoffs are: i) Affymetrix (p-value ~1|10{5), ii) RNA-seq
(p-value ~3|10{6). The smaller number of sQTLs in the RNA-
seq data may be due to lower power in the RNA-seq data, except
for the highest expressed genes (Supplemental Figure 15 of [13]).
(PDF)
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